ALS/MND Natural History Study Data Repository

NCT05966038 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 5000

Last updated 2026-05-20

No results posted yet for this study

Summary

This is a data repository for multi-site multi-protocol clinic-based Natural History Study of ALS and Other Motor Neuron Disorders (MND).

All people living with ALS or other MNDs who attend clinics at the Study hospitals (sites) are offered to participate in the Study.

The Sites collect so-called Baseline information including demographics, disease history and diagnosis, family history, etc. At each visit, the Sites also collect multiple disease-specific outcome measures and events. The information is captured in NeuroBANK, a patient-centric clinical research platform.

The Sites have an option to choose to collect data into 20+ additional forms capturing biomarkers and outcome measures. Captured data after its curation are anonymized (all personal identifiers and dates are being removed), and the anonymized dataset is shared with medical researchers via a non-exclusive revocable license.

Funding Source - Biogen, Inc.; Mitsubishi Tanabe Pharma America; FDA OOPD.

Conditions

  • ALS
  • PLS
  • MND (Motor Neurone DIsease)
  • Kennedy Disease
  • PMA - Progressive Muscular Atrophy
  • PBP - Progressive Bulbar Palsy

Sponsors & Collaborators

  • Henry Ford Health System

    collaborator OTHER
  • Northwestern University

    collaborator OTHER
  • Temple University

    collaborator OTHER
  • St. Louis University

    collaborator OTHER
  • University of Florida

    collaborator OTHER
  • University of Minnesota

    collaborator OTHER
  • Virginia Commonwealth University

    collaborator OTHER
  • Fondazione Serena Onlus - Centro Clinico NeMO Milano

    collaborator OTHER
  • Providence Health & Services

    collaborator OTHER
  • University of Pittsburgh

    collaborator OTHER
  • Istituti Clinici Scientifici Maugeri SpA

    collaborator OTHER
  • Lahey Clinic

    collaborator OTHER
  • Hadassah Medical Organization

    collaborator OTHER
  • Tel Aviv Medical Center

    collaborator OTHER
  • Kaiser Permanente

    collaborator OTHER
  • Trinity Health Michigan

    collaborator OTHER
  • Thomas Jefferson University

    collaborator OTHER
  • Massachusetts General Hospital

    lead OTHER

Principal Investigators

  • Alexander Sherman · Massachusetts General Hospital

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-04-01
Primary Completion
2030-12-31
Completion
2030-12-31

Countries

  • United States
  • Israel
  • Italy

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05966038 on ClinicalTrials.gov